Switzerland· 69446002
Yuvanci 10 mg/40 mg, Filmtabletten
A macitentan and tadalafil product containing macitentanum, tadalafilum, registered in Switzerland by Janssen-Cilag AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Macitentan and tadalafil is registered in 11 of 19 countries.
Countries holding a registration under ATC C02KX54 (macitentan and tadalafil), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Macitentan and tadalafil · ATC C02KX54
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- macitentanum, tadalafilum
- Manufacturer
- Janssen-Cilag AG
- Country
- Switzerland (CH)
- ATC code
- C02KX54
- ATC class
- Macitentan and tadalafil
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680694460026Blist 30 StkCHF 2781.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Macitentan and tadalafil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandYuvanciJanssen-Cilag International NV
- CzechiaYUVANCIJanssen-Cilag International N.V., Beerse
- SpainYUVANCI 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
- IrelandYuvanci 10 mg/20 mg film-coated tabletsJanssen Pharmaceutica NV
- IcelandYuvanciJanssen-Cilag International NV*
- NetherlandsYuvanci 10 mg/20 mg filmomhulde tablettenJanssen-Cilag International NV
- PolandYuvanciJanssen-Cilag International N.V.
- SwedenYuvanci 10 mg/20 mg Filmdragerad tablettJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Yuvanci
- Liechtenstein · Yuvanci
- Norway · Yuvanci
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2c0c73a-5535-4e27-be85-a98877bd42de GET /v1/drugs/f2c0c73a-5535-4e27-be85-a98877bd42de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "macitentanum 10 mg + tadalafilum 40 mg",
"valid_from": "2025-03-01",
"limitations": "[{\"description\":\"YUVANCI wird für die Langzeitbehandlung der pulmonalen arteriellen Hypertonie (PAH) der WHO-Funktionsklasse II-III bei erwachsenen Patienten zur Reduktion der Morbidität vergütet.<br>\\nYUVANCI wird nur bei Patienten vergütet, welche zuvor mit stabilen Dosen von Macitentan 10 mg sowie Tadalafil 40 mg als separate Tabletten im Rahmen der PAH sowie innerhalb der jeweiligen Limitierungen behandelt wurden.<br>\\nDie Verordnung und die Verlaufskontrolle dürfen ausschliesslich durch einen Facharzt / eine Fachärztin für Pneumologie oder Kardiologie mit Erfahrung in der Behandlung von pulmonaler arterieller Hypertonie (PAH) erfolgen.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-03-01\"}]",
"galenic_form": "Filmtabl 10 mg/40 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2025-03-01",
"self_retention_pct": 10
}See everything about macitentan and tadalafil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.